Effect of Lower Leg Heating and Transcutaneous Electrical Nerve Stimulation on Exercise Capacity in Patients With PAD

March 5, 2018 updated by: Salisbury University

The Acute Effects of Leg Heating and Transcutaneous Electrical Nerve Stimulation on Leg Blood Flow and Functional Capacity in Those With Peripheral Arterial Disease

Peripheral arterial disease (PAD) is characterized by poor circulation in the lower extremities that often provokes claudication (leg pain, numbness, and heaviness) with physical exertion. The aim of this research protocol is to determine the effect of two non-invasive treatment modalities on leg blood flow and exercise capacity in those with PAD. Specifically, we are measuring popliteal artery blood flow (Doppler ultrasound), toe oxygen saturation, ankle-brachial index (ABI), and 6-minute walking distance (6MWD) in men and women who have intermittent claudication (Fontaine Stage II; Rutherford Category 1-2) in response to 15 or 45 minutes of lower limb heating and transcutaneous electrical nerve stimulation (TENS).

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Intermittent claudication (Fontaine Stage II)
  • Resting ankle-brachial index (ABI) < 0.90
  • Ability to walk > 60 meters in six minutes

Exclusion Criteria:

  • Body mass index (BMI) > 35 kg/m2
  • Severe exercise limitations (more than PAD) due to co-morbidity
  • Taking illegal/recreational drugs
  • Uncontrolled hypertension (>180/100 mmHg)
  • Severe peripheral neuropathy
  • Foot ulcers
  • Gangrene
  • Pregnant or breast feeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Experimental: 15 minute lower leg heating
Immersion of lower legs in a circulating water bath at a temperature of 42 degrees Celsius
Experimental: 45 minute lower leg heating
Immersion of lower legs in a circulating water bath at a temperature of 42 degrees Celsius
Experimental: 15 minute lower leg TENS
Bilateral lower leg transcutaneous electrical nerve stimulation (TENS) using burst mode at a 3Hz burst rate, 100Hz frequency, and 250 µs pulse duration, sufficient to evoke skeletal muscle contraction
Experimental: 45 minute lower leg TENS
Bilateral lower leg transcutaneous electrical nerve stimulation (TENS) using burst mode at a 3Hz burst rate, 100Hz frequency, and 250 µs pulse duration, sufficient to evoke skeletal muscle contraction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distance walked during six-minute walk test
Time Frame: 35 minutes post-intervention/control
Distance walked during a self-paced six-minute walk
35 minutes post-intervention/control

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Popliteal artery blood flow
Time Frame: Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control
Unilateral popliteal blood flow measured via Doppler ultrasound
Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control
Time/distance to claudication during six-minute walk
Time Frame: 35 minutes following each intervention and control period
Subjects give subjective ratings of claudication onset, if applicable, during six-minute walk test
35 minutes following each intervention and control period
Ankle brachial index (ABI)
Time Frame: Pre-intervention baseline and 20 minutes post-intervention/control
Systolic blood pressures (SBP) are measured in the brachial arteries of both arms and in the posterior tibial and dorsalis pedis arteries of both ankles using a hand-held Doppler ultrasound probe and a sphygmomanometer
Pre-intervention baseline and 20 minutes post-intervention/control
Toe oxygen saturation
Time Frame: Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control
A pulse oximeter is used to measure toe oxygen saturation in the big toe of each of the subject's feet
Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas K. Pellinger, Ph.D., Salisbury University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2015

Primary Completion (Anticipated)

June 1, 2018

Study Completion (Anticipated)

June 1, 2018

Study Registration Dates

First Submitted

February 13, 2018

First Submitted That Met QC Criteria

March 5, 2018

First Posted (Actual)

March 12, 2018

Study Record Updates

Last Update Posted (Actual)

March 12, 2018

Last Update Submitted That Met QC Criteria

March 5, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Arterial Disease

Clinical Trials on Lower leg heating

Subscribe